363 followers
[VEGF] Phase I-II study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal ce... http://t.co/m2UNuyVi PM
[VEGF] Phase I-II study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal ce... http://t.co/m2UNuyVi PM
Phase I-II study of everolimus & Low-dose oral cyclophosphamide in pts w metastatic #RenalCellCancer http://t.co/Iu7pNIYi